Baymatob

24/03/2023

In a recently completed 500 patient Pilot study, Oli has shown significant promise in being able to provide early-warning for post-partum hemorrhage - the leading cause of preventable maternal death, globally. This is a world first achievement, that we are very proud of, and one we hope, in time will help to improve the health outcomes of many mothers and their babies around the world, by becoming the new standard of care.

We are very proud to share our progress with Oli as we aim to revolutionise maternal and fetal monitoring.
Oli is our novel wearable maternal sensor, that aims to provide early warning for complications, before they arise, allowing for planned, proactive and preventative care.

Thank you Gabriella Rogers and Nine for helping to share our story.

An Australian innovation, called Oli, was created to improve the way women are monitored at the pointy end of their pregnancy.

22/03/2022

We are thrilled to announce we have closed our Series A fundraise, led by Australian Unity Future of Healthcare fund, and supported by a stellar cast of impact and MedTech investors.

We are looking forward to continuing our mission to transform health outcomes for mothers and their babies, first by tackling the leading cause of preventable maternal death, postpartum hemorrhage - via our AI-enabled technology, Oli.

Personal experience led to the discovery by engineer Sarah McDonald that there had been no genuine innovation in maternal-fetal monitoring since the 1960s.

21/03/2022

We are thrilled to announce we have closed our Series A fundraise, led by Australian Unity Future of Healthcare fund, and supported by a stellar cast of impact and MedTech investors.

We are looking forward to continuing our mission to transform health outcomes for mothers and their babies, first by tackling the leading cause of preventable maternal death, postpartum hemorrhage - via our AI-enabled technology, Oli.

Personal experience led to the discovery by engineer Sarah McDonald that there had been no genuine innovation in maternal-fetal monitoring since the 1960s.

04/03/2022

We are preparing for an exciting growth stage. In anticipation and support of this growth Dr Sarah McDonald has been appointed Chief Visionary Officer and Founder, and Tony Barclay has been appointed Chair of the Board.

Baymatob™, a pioneer in women’s health and AI-guided monitoring for pregnancy and labour, is preparing for an exciting growth stage. In anticipation and support of this growth Dr Sarah McDonald has been appointed Chief Visionary Officer and Founder, and Tony Barclay has been appointed Chair of t...

07/10/2021

Congratulations to Tara Croft for her appointment as CEO of Baymatob, Tony Barclay as acting CFO and to Sarah McDonald as Chair of the Board. https://baymatob.com/xyz/index.php/news

15/08/2021

Baymatob has been granted FDA Breakthrough Device Designation for Oli.

Oli intends to provide advance diagnosis of the leading cause of maternal death globally, postpartum haemorrhage, aiming to save lives and reduce the occurrence of irreversibly debilitating outcomes, such as emergency hysterectomy.



https://baymatob.com/xyz/index.php/news

10/06/2021

Fantastic collaboration meeting this week on the progress of our Oli Pilot trial at Royal North Shore Hospital.

A big shoutout and thank you to Deborah Wilcox, Michael Nicholl, Michelle De Vroome, Kate Pigott, Sue Nettleton and the fabulous team as RNSH Birthing and Maternity units for helping us to work towards transforming health outcomes for mothers and their babies.

(A special mention our smallest team member, Alex, who also joined meetings) Sarah McDonald, Baymatob

07/12/2020

Looking forward to the launch of the centre for Robotics & Health Technology Research. Tune in online tomorrow (TUES, 8 DEC, 1130AM AEST) to hear about this exciting centre.

24 hours to go!

Please join us tomorrow at 11:30AM (AEDT) for the official introduction for our centre for Robotics and Health Technology!

Tuesday 8th December 2020
11:30AM - 12:30PM (AEDT)
Tune in HERE: https://inghaminstitute.org.au/roboticsandhealthtechnologylive/

01/09/2020

Starting today each of you can help us improve outcomes and experience during pregnancy and labour by supporting the Baymatob team as they step up for Cerebral Palsy and take part in STEPtember.

Cerebral Palsy is known to be caused by damage to the developing brain either during pregnancy or shortly after birth. Noting this participating in STEPtember gives the Baymatob team another way we can help improve outcomes and experience in pregnancy and labour.



https://www.steptember.org.au/fundraisers/baymatoboperationsptyltd